Filing Flows › Korro Bio (KRRO) › Q2 2025
Korro Bio (KRRO) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 12, 2025
Korro Bio (KRRO) reported revenue of $1.5M for the second quarter 2025 (Q2 2025) and -43% from the quarter before.
Korro Bio, Q2 2025: revenue $1.5M, net loss $25.8M, operating cash flow −$19.2M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5M | -43% | — |
| Operating profit | −$27.2M | — | — |
| Net earnings | −$25.8M | — | — |
| Operating cash flow | −$19.2M | — | — |
What changed
Revenue was $1.5M in Q2 2025, down 43% from the previous quarter.
Operating costs exceeded revenue by $27.2M, an operating margin of -1863.2%. The quarter ended with a net loss of $25.8M, wider than the previous quarter's $23.4M loss.
Operating cash flow was −$19.2M. Non-cash charges added back $1.2M of depreciation and $2.0M of share-based compensation. Working capital and other items added $3.3M. Capital expenditures of $140K exceeded it, leaving free cash flow of −$19.4M.
Questions
What was Korro Bio's revenue in the second quarter 2025?
Korro Bio (KRRO) reported revenue of $1.5M for the second quarter 2025 (Q2 2025) and -43% from the quarter before.
Source: Korro Bio 10-Q on SEC EDGAR.